Skip to main content
. Author manuscript; available in PMC: 2017 Nov 14.
Published in final edited form as: Clin Pharmacol Ther. 2016 Aug 18;100(4):380–388. doi: 10.1002/cpt.411

Table 1.

CPIC important genes included a total of 127 CPIC important variants

Gene Number of CPIC important variants Affymetrix DMET
and add-on assays
Whole exome
sequencing
Whole genome
sequencing
SNV (exonic) Indel (exonic) Other Total
CFTR 10 (1N0) 2 (2) 12 Not interrogated 12 12
CYP2C19 8 (7) 0 8 8 7 8
CYP2C9 10 (10) 2 (2) 12 10 12 12
CYP2D6 26 (24) 13 (13) 2 structural variations 41 23 and two structural variations 36 and CYP2D6 copy number (missing CYP2D6/2D7 hybrid) 35 and CYP2D6 copy number (missing CYP2D6/2D7 hybrid, lower call rate due to copy number variation)
CYP3A5 2 (1) 1 (1) 3 3 2 (missing important variants) 3
DPYD 10 (10) 2 (2) 12 9 (missing important variants) 12 12
G6PD 7 (7) 0 7 4 (missing important variants) 7 2 (lowercall rate due to copy number variation)
HLA-B 0 0 1 haplotype 1 Not interrogated 1 1
IFNL3 2 (0) 0 2 Not interrogated Missing important variants 2
SLCO1B1 12 (11) 0 12 10 11 12
TPMT 15 (15) 0 15 5 15 15
UGT1A1 0 1 (0) 1 Low call rate 1 1
VKORC1 1 (0) 0 1 1 Missing important variants 1
Total 103 (95) 21 (20) 3 127

Genotyping performance by DMET, WES, and WGS is summarized as the number of variants interrogated with call rate >98%.